XML 18 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF INCOME (USD $)
In Thousands, except Per Share data
3 Months Ended 12 Months Ended
Mar. 31, 2011
Mar. 31, 2010
Mar. 31, 2009
Mar. 31, 2011
Mar. 31, 2010
Mar. 31, 2009
CONSOLIDATED STATEMENTS OF INCOME [Abstract]            
Net sales $ 379,985 $ 278,020   $ 1,487,205 $ 947,729 $ 903,297
Cost of sales (1)       612,769 [1] 413,487 [2] 386,793 [3]
Gross profit 225,591 168,471   874,436 534,242 516,504
Operating expenses:            
Research and development (1)       170,607 [1] 120,823 [2] 115,524 [3]
Selling, general and administrative (1)       227,781 [1] 167,222 [2] 161,218 [3]
Special charges       1,865 1,238 6,434
Total operating expenses       400,253 289,283 283,176
Operating income 124,361 88,487   474,183 244,959 233,328
Gains on equity method investments       157 0 0
Other income (expense):            
Interest income       16,002 15,325 32,545
Interest expense       31,521 31,150 29,440
Other, net       1,877 8,679 (4,354)
Income from continuing operations before income taxes 460,698 237,813 232,079      
Income tax provision (benefit)       31,531 20,808 (13,508)
Net income from continuing operations 130,612     429,167 217,005 245,587
Discontinued operations:            
Loss from discontinued operations before income taxes       (11,126) 0 0
Income tax benefit       (909) 0 0
Net loss from discontinued operations (5,084)     (10,217) 0 0
Net income       $ 418,950 $ 217,005 $ 245,587
Basic net income per common share - continuing operations       $ 2.29 $ 1.18 $ 1.34
Basic net loss per common share - discontinued operations       $ (0.05) $ 0.00 $ 0.00
Basic net income per common share       $ 2.24 $ 1.18 $ 1.34
Diluted net income per common share - continuing operations $ 0.65     $ 2.20 $ 1.16 $ 1.31
Diluted net loss per common share - discontinued operations $ (0.03)     $ (0.05) $ 0.00 $ 0.00
Diluted net income per common share $ 0.62 $ 0.40   $ 2.15 $ 1.16 $ 1.31
Dividends declared per common share       $ 1.374 $ 1.359 $ 1.346
Basic common shares outstanding       187,066 183,642 183,158
Diluted common shares outstanding       194,715 187,339 186,788
[1] Includes share-based compensation expense as follows: Cost of sales 6,825 Research and development 12,874 Selling, general and administrative 17,113
[2] Includes share-based compensation expense as follows: Cost of sales 7,054 Research and development 12,194 Selling, general and administrative 17,530
[3] Includes share-based compensation expense as follows: Cost of sales 5,845 Research and development 10,866 Selling, general and administrative 15,770